AAAAAA
Results:
1-14
|
Results: 14
Authors:
MANUSAMA ER
NOOIJEN PTGA
TENHAGEN TLM
VANDERVEEN AH
DEVRIES MWR
DEWILT JHW
VANIJKEN MG
MARQUET RL
EGGERMONT AMM
Citation: Er. Manusama et al., TUMOR-NECROSIS-FACTOR-ALPHA IN ISOLATED PERFUSION SYSTEMS IN THE TREATMENT OF CANCER - THE ROTTERDAM PRECLINICAL-CLINICAL PROGRAM, Seminars in surgical oncology, 14(3), 1998, pp. 232-237
Authors:
DEWILT JHW
MANUSAMA ER
VANTIEL ST
VANIJKEN MGA
TENHAGEN TLM
EGGERMONT AMM
Citation: Jhw. Dewilt et al., PREREQUISITES FOR EFFECTIVE ISOLATED LIMB PERFUSION USING TUMOR-NECROSIS-FACTOR-ALPHA AND MELPHALAN IN RATS, European journal of cancer, 34, 1998, pp. 165-165
Authors:
VANIJKEN MGA
DEBRUIJN EA
WIGGERS T
VANEIJCK CHJ
VANDERSIJP JRM
TENHAGEN TLM
EGGERMONT AMM
Citation: Mga. Vanijken et al., HYPOXIC PERFUSION OF PELVIS, ABDOMEN AND LIVER WITH TNF-ALPHA MELPHALAN AND MITOMYCIN-C USING NEW BALLOON CATHETER TECHNIQUES - PHARMACOKINETICS IN PIGS, European journal of cancer, 34, 1998, pp. 180-180
Authors:
VANDERVEEN AH
EGGERMONT AMM
TENHAGEN TLM
Citation: Ah. Vanderveen et al., STEALTH(R) LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOLID TUMOR TREATMENT, International journal of pharmaceutics, 162(1-2), 1998, pp. 87-94
Authors:
VANDERVEEN AH
EGGERMONT AMM
SEYNHAEVE ALB
VANTIEL ST
TENHAGEN TLM
Citation: Ah. Vanderveen et al., BIODISTRIBUTION AND TUMOR-LOCALIZATION OF STEALTH LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOFT-TISSUE SARCOMA-BEARING RATS, International journal of cancer, 77(6), 1998, pp. 901-906
Authors:
TENHAGEN TLM
VANVIANEN W
SAVELKOUL HFJ
HEREMANS H
BUURMAN WA
BAKKERWOUDENBERG IAJM
Citation: Tlm. Tenhagen et al., INVOLVEMENT OF T-CELLS IN ENHANCED RESISTANCE TO KLEBSIELLA-PNEUMONIAE SEPTICEMIA IN MICE TREATED WITH LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE OR GAMMA-INTERFERON, Infection and immunity, 66(5), 1998, pp. 1962-1967
Authors:
TENHAGEN TLM
EGGERMONT AMM
Citation: Tlm. Tenhagen et Amm. Eggermont, A RAT EXTREMITY SOFT-TISSUE SARCOMA MODEL FOR THE STUDY OF SYSTEMIC TREATMENT WITH STEALTH(R) LIPOSOME-ENCAPSULATED TUMOR-NECROSIS-FACTOR-ALPHA AND CYTOTOXIC AGENTS, Advanced drug delivery reviews, 24(2-3), 1997, pp. 245-256
Authors:
EGGERMONT AMM
MANUSAMA ER
TENHAGEN TLM
Citation: Amm. Eggermont et al., REGIONAL APPLICATION OF TNF-ALPHA IN THE TREATMENT OF CANCER - A PRECLINICAL-CLINICAL INTERACTIVE PROGRAM, Journal of inflammation, 47(1-2), 1996, pp. 104-113
Authors:
TENHAGEN TLM
VANVIANEN W
BAKKERWOUDENBERG IAJM
Citation: Tlm. Tenhagen et al., ISOLATION AND CHARACTERIZATION OF MURINE KUPFFER CELLS AND SPLENIC MACROPHAGES, Journal of immunological methods, 193(1), 1996, pp. 81-91
Authors:
BERGERS JJ
TENHAGEN TLM
VANETTEN EWM
BAKKERWOUDENBERG IAJM
Citation: Jj. Bergers et al., LIPOSOMES AS DELIVERY SYSTEMS IN THE PREVENTION AND TREATMENT OF INFECTIOUS-DISEASES, Pharmacy world & science, 17(1), 1995, pp. 1-11
Authors:
TENHAGEN TLM
VOSSEN ACTM
VANVIANEN W
TIBBE GJM
SAVELKOUL HFJ
HEREMANS H
BAKKERWOUDENBERG IAJM
Citation: Tlm. Tenhagen et al., ENHANCEMENT OF NONSPECIFIC RESISTANCE BY LIPOSOME-ENCAPSULATED IMMUNOMODULATORS DOES NOT AFFECT SKIN-GRAFT REJECTION IN MICE, Transplantation, 60(11), 1995, pp. 1211-1214
Authors:
TENHAGEN TLM
VANVIANEN W
BAKKERWOUDENBERG IAJM
Citation: Tlm. Tenhagen et al., MODULATION OF NONSPECIFIC ANTIMICROBIAL RESISTANCE OF MICE TO KLEBSIELLA-PNEUMONIAE SEPTICEMIA BY LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE AND INTERFERON-GAMMA ALONE OR COMBINED, The Journal of infectious diseases, 171(2), 1995, pp. 385-392
Authors:
DEGRAAFMILTENBURG LAM
VANVLIET KE
TENHAGEN TLM
VERHOEF J
VANSTRIJP JAG
Citation: Lam. Degraafmiltenburg et al., THE VOLE OF HSV-INDUCED FC- AND C3B(I)-RECEPTORS IN BACTERIAL ADHERENCE, Journal of Medical Microbiology, 40(1), 1994, pp. 48-54
Authors:
TENHAGEN TLM
SULZER AJ
KIDD MR
LAL AA
HUNTER RL
Citation: Tlm. Tenhagen et al., ROLE OF ADJUVANTS IN THE MODULATION OF ANTIBODY ISOTYPE, SPECIFICITY,AND INDUCTION OF PROTECTION BY WHOLE BLOOD-STAGE PLASMODIUM-YOELII VACCINES, The Journal of immunology, 151(12), 1993, pp. 7077-7085
Risultati:
1-14
|